Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Eastern District of Pennsylvania on February 22, 2024. The debtor listed its assets of $0.05 million and liabilities in the range of $16.23 million. The debtor is represented by David B. Smith of Smith Kane Holman, LLC as its legal counsel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0108 USD | +3.40% | +8.00% | -50.91% |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-50.91% | 548K | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- BXRX.Q Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. Filed for Bankruptcy